Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

2581 - 2590 of 3850 results found

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update from the American College of Physicians

MeSH Terms

Hemoglobin A; Glycosylated (D12.776.422.316.762.380.440); Hemoglobin A; Glycosylated (D12.776.124.400.405.440); Hemoglobin A; Glycosylated (D09.408.375); Diabetes Mellitus; Type 2 (C19.246.300); Therapeutic Uses (D27.505.954); Metformin (D02.078.370.141.450); Thiazolidinediones (D02.886.675.933); Dipeptidyl Peptidase 4 (D23.050.301.264.035.283); Diabetes Mellitus (C19.246); Drug Therapy; Combination (E02.319.310); Dipeptidyl-Peptidase IV Inhibitors (D27.505.696.422.500); Sodium-Glucose Transporter 2 (D12.776.157.530.500.750.750); Sodium-Glucose Transporter 2 (D12.776.543.585.500.750.750); Dipeptidyl-Peptidase IV Inhibitors (D27.505.519.389.745.335)

Guideline Contact
Amir Qaseem ([email protected])
Publication Date
01/03/2017
Date of Last Evidence Search
12/2015
Methods Applied
See Publication
Publication Scope
Treatment
Countries of Application
United States
Guideline Publication Status
Inactive
Languages
English
Authors
ACP (US)
Publication Year
2017

Organizational Guideline for Gynecologic Oncology Services in Ontario

MeSH Terms

Organizational Policy (I01.655.500.550); Health Facilities (N02.278); Centralized Hospital Services (N02.278.354.110); Clinical Competence (I02.399.630.210)

Guideline Contact
Cindy Walker-Dilks ([email protected])
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2013